NO975987L - 4-Fenylaminotiazol-derivater, fremgangsmåte for fremstilling av disse og farmasöytiske blandinger inneholdende nevnte derivater - Google Patents

4-Fenylaminotiazol-derivater, fremgangsmåte for fremstilling av disse og farmasöytiske blandinger inneholdende nevnte derivater

Info

Publication number
NO975987L
NO975987L NO975987A NO975987A NO975987L NO 975987 L NO975987 L NO 975987L NO 975987 A NO975987 A NO 975987A NO 975987 A NO975987 A NO 975987A NO 975987 L NO975987 L NO 975987L
Authority
NO
Norway
Prior art keywords
alkyl
group
radical
cycloalkyl
moiety
Prior art date
Application number
NO975987A
Other languages
English (en)
Norwegian (no)
Other versions
NO975987D0 (no
Inventor
Danielle Gully
Pierre Roger
Camille Georges Wermuth
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of NO975987D0 publication Critical patent/NO975987D0/no
Publication of NO975987L publication Critical patent/NO975987L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/02Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • A61P5/04Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin for decreasing, blocking or antagonising the activity of the hypothalamic hormones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38Nitrogen atoms
    • C07D277/42Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO975987A 1995-06-21 1997-12-19 4-Fenylaminotiazol-derivater, fremgangsmåte for fremstilling av disse og farmasöytiske blandinger inneholdende nevnte derivater NO975987L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9507437A FR2735777B1 (fr) 1995-06-21 1995-06-21 Derives de 4-phenylaminothiazole, leur procede de preparation et les compositions pharmaceutiques les contenant
PCT/FR1996/000941 WO1997000868A1 (fr) 1995-06-21 1996-06-18 Derives de 4-phenylaminothiazole, leur procede de preparation et les compositions pharmaceutiques les contenant

Publications (2)

Publication Number Publication Date
NO975987D0 NO975987D0 (no) 1997-12-19
NO975987L true NO975987L (no) 1998-02-19

Family

ID=9480235

Family Applications (1)

Application Number Title Priority Date Filing Date
NO975987A NO975987L (no) 1995-06-21 1997-12-19 4-Fenylaminotiazol-derivater, fremgangsmåte for fremstilling av disse og farmasöytiske blandinger inneholdende nevnte derivater

Country Status (22)

Country Link
US (1) US5880135A (cs)
EP (1) EP0833822A1 (cs)
JP (1) JP3067807B2 (cs)
KR (1) KR19990028325A (cs)
AU (1) AU710300B2 (cs)
BR (1) BR9609420A (cs)
CA (1) CA2222266A1 (cs)
CZ (1) CZ410397A3 (cs)
EE (1) EE9700333A (cs)
FR (1) FR2735777B1 (cs)
HU (1) HUP9900056A2 (cs)
IL (1) IL122293A0 (cs)
IS (1) IS4635A (cs)
NO (1) NO975987L (cs)
NZ (1) NZ312157A (cs)
PL (1) PL324202A1 (cs)
RU (1) RU2146253C1 (cs)
SK (1) SK171197A3 (cs)
TR (1) TR199701654T1 (cs)
TW (1) TW416952B (cs)
WO (1) WO1997000868A1 (cs)
ZA (1) ZA965294B (cs)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7094782B1 (en) 1996-07-24 2006-08-22 Bristol-Myers Squibb Company Azolo triazines and pyrimidines
US6060478A (en) * 1996-07-24 2000-05-09 Dupont Pharmaceuticals Azolo triazines and pyrimidines
US6191131B1 (en) 1997-07-23 2001-02-20 Dupont Pharmaceuticals Company Azolo triazines and pyrimidines
US6124289A (en) * 1996-07-24 2000-09-26 Dupont Pharmaceuticals Co. Azolo triazines and pyrimidines
US6313124B1 (en) 1997-07-23 2001-11-06 Dupont Pharmaceuticals Company Tetrazine bicyclic compounds
FR2754258B1 (fr) 1996-10-08 1998-12-31 Sanofi Sa Derives d'aminothiazole, leur procede de preparation et les compositions pharmaceutiques les contenant
US6187777B1 (en) * 1998-02-06 2001-02-13 Amgen Inc. Compounds and methods which modulate feeding behavior and related diseases
AU755552B2 (en) 1998-11-12 2002-12-12 Neurocrine Biosciences, Inc. CRF receptor antagonists and methods relating thereto
AU755997B2 (en) * 1998-11-12 2003-01-02 Neurocrine Biosciences, Inc. CRF receptor antagonists and methods relating thereto
US6531475B1 (en) 1998-11-12 2003-03-11 Neurocrine Biosciences, Inc. CRF receptor antagonists and methods relating thereto
FR2796380B3 (fr) 1999-07-15 2001-08-17 Sanofi Synthelabo Nouveaux derives d'aminothiazoles, leur preparation et les compositions pharmaceutiques les contenant
FR2819508B1 (fr) * 2001-01-12 2005-01-21 Sod Conseils Rech Applic Derives de 2-arylimino-2, 3-dihydorthiazoles, leurs procedes de preparation et leur utilisation therapeutiques
US6432989B1 (en) * 1999-08-27 2002-08-13 Pfizer Inc Use of CRF antagonists to treat circadian rhythm disorders
CO5271670A1 (es) 1999-10-29 2003-04-30 Pfizer Prod Inc Antagonistas del factor de liberacion de corticitropina y composiciones relacionadas
AU2001234180A1 (en) * 2000-02-25 2001-09-03 Japan Tobacco Inc. Benzamide derivative and use thereof
EP1149583A3 (en) * 2000-04-13 2001-11-14 Pfizer Products Inc. Combinations of corticotropin releasing factor antagonists and growth hormone secretagogues
DE10045650A1 (de) * 2000-09-15 2002-03-28 Adolf Wuerth Gmbh & Co Kg Kunststoffdübel
US7153871B2 (en) 2001-01-22 2006-12-26 Memory Pharmaceuticals Corporation Phosphodiesterase 4 inhibitors, including aminoindazole and aminobenzofuran analogs
US7205320B2 (en) 2001-01-22 2007-04-17 Memory Pharmaceuticals Corp. Phosphodiesterase 4 inhibitors
WO2003015777A1 (en) * 2001-08-13 2003-02-27 Lion Bioscience Ag Nr1h4 nuclear receptor binding compounds
AU2002240733B2 (en) * 2001-10-18 2009-04-09 Zlatko Ademovic Additive cytoprotective effects of two bioactive regions of pro-opiomelanocortin hormone
WO2004009552A1 (en) 2002-07-19 2004-01-29 Memory Pharmaceuticals Corporation Phosphodiesterase 4 inhibitors, including n-substituted aniline and diphenylamine analogs
NZ537725A (en) * 2002-07-19 2006-08-31 Memory Pharm Corp 6-Amino-1H-indazole and 4-aminobenzofuran compounds as phosphodiesterase 4 inhibitors
AU2003295656B2 (en) 2002-11-19 2010-11-11 Memory Pharmaceuticals Corporation Pyridine N-oxide compounds as phosphodiesterase 4 inhibitors
US20090048255A1 (en) * 2003-07-21 2009-02-19 Schumacher Richard A Phosphodiesterase 4 inhibitors, including n-substituted aniline and diphenylamine analogs
MY141255A (en) * 2003-12-11 2010-03-31 Memory Pharm Corp Phosphodiesterase 4 inhibitors, including n-substituted diarylamine analogs
KR20080091369A (ko) * 2006-01-18 2008-10-10 암젠 인크 단백질 키나제 b (pkb) 억제제로서 티아졸 화합물
US8252333B2 (en) 2006-01-26 2012-08-28 Jorge Cueto-Garcia Biodegradable, non-toxic biological adhesive for use in abdominal surgery
WO2010003084A2 (en) * 2008-07-02 2010-01-07 Memory Pharmaceuticals Corporation Phosphodiesterase 4 inhibitors
EP3137454A1 (en) 2014-04-28 2017-03-08 Pfizer Inc. Heteroaromatic compounds and their use as dopamine d1 ligands

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2612187B1 (fr) * 1987-03-12 1989-07-21 Sanofi Sa Derives du thiazole actifs sur le systeme cholinergique, leur procede de preparation et compositions pharmaceutiques en contenant
GB8724566D0 (en) * 1987-10-20 1987-11-25 Roussel Lab Ltd Chemical compounds
FR2656610B1 (fr) * 1989-12-29 1992-05-07 Sanofi Sa Derives d'amino-2 phenyl-4 thiazole, leur procede de preparation et leur application therapeutique.
FR2692893B1 (fr) * 1992-06-24 1994-09-02 Sanofi Elf Dérivés alkylamino ramifiés du thiazole, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent.

Also Published As

Publication number Publication date
NZ312157A (en) 1999-04-29
ZA965294B (en) 1997-12-22
SK171197A3 (en) 1998-08-05
AU6362796A (en) 1997-01-22
TR199701654T1 (xx) 1998-05-21
JP3067807B2 (ja) 2000-07-24
MX9710378A (es) 1998-07-31
RU2146253C1 (ru) 2000-03-10
FR2735777B1 (fr) 1997-09-12
EE9700333A (et) 1998-06-15
HUP9900056A2 (hu) 1999-05-28
WO1997000868A1 (fr) 1997-01-09
FR2735777A1 (fr) 1996-12-27
CZ410397A3 (cs) 1998-04-15
JPH10511693A (ja) 1998-11-10
US5880135A (en) 1999-03-09
IS4635A (is) 1997-12-16
NO975987D0 (no) 1997-12-19
PL324202A1 (en) 1998-05-11
AU710300B2 (en) 1999-09-16
BR9609420A (pt) 1999-05-18
IL122293A0 (en) 1998-04-05
EP0833822A1 (fr) 1998-04-08
CA2222266A1 (fr) 1997-01-09
TW416952B (en) 2001-01-01
KR19990028325A (ko) 1999-04-15

Similar Documents

Publication Publication Date Title
NO975987L (no) 4-Fenylaminotiazol-derivater, fremgangsmåte for fremstilling av disse og farmasöytiske blandinger inneholdende nevnte derivater
NO970511L (no) Nye substituerte oksazolidinoner
PT83310A (de) Heterocyclish substitutierte indole zwischenprodukte verfahren zu ihrer herstellung und arzneimittel
EP0040639A4 (en) Isoxazole derivatives.
NZ532494A (en) Dibenzylamine compound and medicinal use thereof
NO990227L (no) Heterocykliske forbindelser som farmas°ytika
IE891797L (en) 4-amino quinolines and naphthyridines, process for their¹preparation and their use as medicines
HRP20070117T8 (en) Heterocyclic oxime derivatives, process for their preparation and use thereof in the treatment of type ii diabetes
HU900636D0 (en) Process for preparation of new tetrahydro-benzimidazole derivatives and pharmaceutical compositions containing the above compounds
ATE3638T1 (de) Sulfonyl-anilin-derivate, verfahren zu ihrer herstellung und ihre therapeutische verwendung.
ATE19776T1 (de) Neue substituierte 1,4-dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
DK118287A (da) Heteroaryloxy-beta-carbolinderivater, deres fremstilling og deres anvendelse som laegemiddel
ES8300745A1 (es) Un procedimiento para la preparacion de nuevos derivados de la quinoleina.
ES466366A1 (es) Un procedimiento para preparar derivados de metasulfonamido-benzamida.
DK393486A (da) Dihydropyridin-derivater og fremgangsmaade til fremstilling deraf
IE782028L (en) Substituted furans
ES413043A1 (es) Procedimiento para preparar derivados de rifamicina.
ATE8389T1 (de) Amino-alkoxy-pyrazole, verfahren zu ihrer herstellung und diese enthaltende arzneimittel.
PL304226A1 (en) Derivatives of pyrimidinyloacrylic acid and method of obtaining such derivatives
NO941073L (no) Fenylglycinamid av heterocykliske, substituerte fenyleddiksyrederivater
DE69915471D1 (de) Analoga von distamycin-zimtsäurederivaten, verfahren zu ihrer herstellung und ihre verwendung als antitumormittel
KR960703406A (ko) 치환된 아릴티오알킬티오피리딘(substituted arylthioalkylthiopyrdines)
IL59053A0 (en) N-azolyl-acetanilides their manufacture and their use as fungicides
TW350843B (en) 2-(4-pyrazolyloxy-pyrimidin-5-yl) acetic acid derivatives
NO982549L (no) 5-naftalen-1-yl-1,3-dioksan-derivater, fremstilling og terapeutisk anvendelse derav

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application